Description(s) found:
SHOW ONLY BEST
|
gi|90109109|pdb|2CDD|B Chain B, Human Hsp90 With 4-(4-(2,3-Dihydro-Benzol(1,4)dioxin-6-Yl)- 5-Methyl-1h-Pyrazol-3-Yl)-6-Ethyl-Benzene-1,3-Diol
[NCBI NR]
gi|90109108|pdb|2CDD|A Chain A, Human Hsp90 With 4-(4-(2,3-Dihydro-Benzol(1,4)dioxin-6-Yl)- 5-Methyl-1h-Pyrazol-3-Yl)-6-Ethyl-Benzene-1,3-Diol
[NCBI NR]
gi|50513864|pdb|1UYL|A Chain A, Structure-Activity Relationships In Purine-Based Inhibitor Binding To Hsp90 Isoforms
[NCBI NR]
gi|50513863|pdb|1UYK|A Chain A, Human Hsp90-Alpha With 8-Benzo[1,3]dioxol-,5-Ylmethyl-9-But Yl-2-Fluoro-9h-Purin-6-Ylamine
[NCBI NR]
gi|50513861|pdb|1UYH|A Chain A, Human Hsp90-Alpha With 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2- Fluoro-9h-Purin-6-Ylamine
[NCBI NR]
gi|50513860|pdb|1UYG|A Chain A, Human Hsp90-Alpha With 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h- Purin-6-Ylamine
[NCBI NR]
gi|50513859|pdb|1UYF|A Chain A, Human Hsp90-Alpha With 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)- 2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
[NCBI NR]
gi|50513858|pdb|1UYE|A Chain A, Human Hsp90-Alpha With 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)- 9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
[NCBI NR]
gi|50513857|pdb|1UYD|A Chain A, Human Hsp90-Alpha With 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy- Benzyl)-9h-Purin-6-Ylamine
[NCBI NR]
gi|50513856|pdb|1UYC|A Chain A, Human Hsp90-Alpha With 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h- Purin-6-Ylamine
[NCBI NR]
gi|50513855|pdb|1UY9|A Chain A, Human Hsp90-Alpha With 8-Benzo[1,3]dioxol-,5-Ylmethyl-9- Butyl-9h-Purin-6-Ylamine
[NCBI NR]
gi|50513854|pdb|1UY8|A Chain A, Human Hsp90-Alpha With 9-Butyl-8-(3-Trimethoxy-Benzyl)-9h- Purin-6ylamine
[NCBI NR]
gi|50513853|pdb|1UY7|A Chain A, Human Hsp90-Alpha With 9-Butyl-8-(4-Methoxy-Benzyl)-9h- Purin-6-Ylamine
[NCBI NR]
gi|50513852|pdb|1UY6|A Chain A, Human Hsp90-Alpha With 9-Butyl-8-(3,4,5-Trimethoxy-Benzyl)- 9h-Purin-6-Ylamine
[NCBI NR]
gi|254839174|pdb|2WI7|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The Hsp90 Chaperone
[NCBI NR]
gi|254839173|pdb|2WI6|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The Hsp90 Chaperone
[NCBI NR]
gi|254839172|pdb|2WI5|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The Hsp90 Chaperone
[NCBI NR]
gi|254839171|pdb|2WI4|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The Hsp90 Chaperone
[NCBI NR]
gi|254839170|pdb|2WI3|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The Hsp90 Chaperone
[NCBI NR]
gi|254839169|pdb|2WI2|B Chain B, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The Hsp90 Chaperone
[NCBI NR]
gi|254839168|pdb|2WI2|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The Hsp90 Chaperone
[NCBI NR]
gi|254839167|pdb|2WI1|A Chain A, Orally Active 2-Amino Thienopyrimidine Inhibitors Of The Hsp90 Chaperone
[NCBI NR]
gi|162330182|pdb|2VCJ|A Chain A, 4,5 Diaryl Isoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents For The Treatment Of Cancer
[NCBI NR]
gi|162330181|pdb|2VCI|A Chain A, 4,5 Diaryl Isoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents For The Treatment Of Cancer
[NCBI NR]
gi|146387173|pdb|2UWD|A Chain A, Inhibition Of The Hsp90 Molecular Chaperone In Vitro And In Vivo By Novel, Synthetic, Potent Resorcinylic Pyrazole, Isoxazole Amide Analogs
[NCBI NR]
Chain A, Structure-Activity Relationships In Purine-Based Inhibitor Binding To Hsp90 Isoformsgi|50513863|pdb|1UYK|A Chain A, Human Hsp90-Alpha With 8-Benzo[1,3]dioxol-,5-Ylmethyl-9-But Yl-2-Fluoro-9h-Purin-6-Ylaminegi|50513861|pdb|1UYH|A Chain A, Human
[nrdb_11152004_Chlamydomonas]
Chain A, 4,5 Diaryl Isoxazole Hsp90 Chaperone Inhibitors: Potential Therapeutic Agents For The Treatment Of Cancer
[NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
Chain A, Inhibition Of The Hsp90 Molecular Chaperone In Vitro And In Vivo By Novel, Synthetic, Potent Resorcinylic Pyrazole, Isoxazole Amide Analogs
[NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
Chain B, Human Hsp90 With 4-(4-(2,3-Dihydro-Benzol(1,4)dioxin-6-Yl)- 5-Methyl-1h-Pyrazol-3-Yl)-6-Ethyl-Benzene-1,3-Diol
[NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
Chain A, Human Hsp90 With 4-(4-(2,3-Dihydro-Benzol(1,4)dioxin-6-Yl)- 5-Methyl-1h-Pyrazol-3-Yl)-6-Ethyl-Benzene-1,3-Diol
[NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
Chain A, Structure-Activity Relationships In Purine-Based Inhibitor Binding To Hsp90 Isoforms
[NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
Chain A, Human Hsp90-Alpha With 8-Benzo[1,3]dioxol-,5-Ylmethyl-9-But Yl-2-Fluoro-9h-Purin-6-Ylamine
[NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
Chain A, Human Hsp90-Alpha With 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-2- Fluoro-9h-Purin-6-Ylamine
[NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
Chain A, Human Hsp90-Alpha With 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h- Purin-6-Ylamine
[NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
Chain A, Human Hsp90-Alpha With 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)- 2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
[NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
Chain A, Human Hsp90-Alpha With 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl)- 9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
[NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
Chain A, Human Hsp90-Alpha With 9-Butyl-8-(2-Chloro-3,4,5-Trimethoxy- Benzyl)-9h-Purin-6-Ylamine
[NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
Chain A, Human Hsp90-Alpha With 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h- Purin-6-Ylamine
[NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
Chain A, Human Hsp90-Alpha With 8-Benzo[1,3]dioxol-,5-Ylmethyl-9- Butyl-9h-Purin-6-Ylamine
[NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
Chain A, Human Hsp90-Alpha With 9-Butyl-8-(3-Trimethoxy-Benzyl)-9h- Purin-6ylamine
[NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
Chain A, Human Hsp90-Alpha With 9-Butyl-8-(4-Methoxy-Benzyl)-9h- Purin-6-Ylamine
[NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
Chain A, Human Hsp90-Alpha With 9-Butyl-8-(3,4,5-Trimethoxy-Benzyl)- 9h-Purin-6-Ylamine
[NCBI-RefSeq_human_na_08-16-2008_con_reversed.fasta]
Chain A, Human Hsp90-Alpha With 8-Benzo[1,3]dioxol-,5-Ylmethyl-9-Butyl-9h-Purin-6-Ylamine
[nr-271106-contam.fasta]
Chain A, Human Hsp90-Alpha With 9-Butyl-8- (2-Chloro-3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
[nr-271106-contam.fasta]
Chain A, Human Hsp90-Alpha With 9-Butyl-8-(4-Methoxy-Benzyl)-9h-Purin-6-Ylamine
[nr-271106-contam.fasta]
Chain A, Human Hsp90-Alpha With 8-(2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
[nr-271106-contam.fasta]
Chain A, Human Hsp90-Alpha With 9-Butyl-8-(3,4,5-Trimethoxy-Benzyl)-9h-Purin-6-Ylamine
[nr-271106-contam.fasta]
Chain A, Human Hsp90-Alpha With 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl) -2-Fluoro-9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
[nr-271106-contam.fasta]
Chain A, Human Hsp90-Alpha With 9-Butyl-8- (2,5-Dimethoxy-Benzyl)-2-Fluoro-9h-Purin-6-Ylamine
[nr-271106-contam.fasta]
Chain A, Human Hsp90-Alpha With 9-Butyl-8-(3-Trimethoxy-Benzyl)-9h-Purin-6ylamine
[nr-271106-contam.fasta]
Chain A, Human Hsp90-Alpha With 8-(2-Chloro-3,4,5-Trimethoxy-Benzyl) -9-Pent-4-Ylnyl-9h-Purin-6-Ylamine
[nr-271106-contam.fasta]
Chain A, Human Hsp90-Alpha With 9-Butyl-8-(2,5-Dimethoxy-Benzyl)-9h-Purin-6-Ylamine
[nr-271106-contam.fasta]
|